Experimental studies have suggested that GLP-1 stimulate proliferation of developed β-cells and inhibits B-cell apoptosis [49], suggesting a potential role of incretin-mimetics in vivo in limiting β-cells dysfunction, which typically occurs in people with type 2 diabetes. This evidence concerns the gene GCG and type 2 diabetes mellitus.